Adem Kurtuluş

Dr. Adem Kurtuluş

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
ÖZÖzkaya Zübeyde
Özkaya Zübeyde
AKAdem Kurtuluş
Adem Kurtuluş
DSDinç Samet
Dinç Samet
Introduction and importance: Covid-19 is an important disease that still occupies our agenda, and as time passes, we have been observing its extrapulmonary manifestations. In this study, we presented a case of spontaneous thoracolumbar epidural hematoma, which we could not attribute to any cause other than Covid-19. Case presentation: We presented a 55-year-old female patient whose etiology could not be found to be compatible with the literature. In the formation of this disease, we did not have any positive findings except for Covid-19, which she had 20 days ago. The patient had no history of anticoagulant or antiaggregant drug use. He had no history of trauma and no signs. Hematological tests were normal. We evacuated the hematoma in the T12-L1 vertebral canal after laminectomy and the pathology result was compatible with hematoma. Clinical discussion: Although spontaneous spinal epidural hematoma is rare, many factors are blamed for its etiology. Many extrapulmonary complications of Covid-19 stand out in the literature. The fact that the patient had Covid-19 did not affect the neurosurgical approach, but we think that it is useful to examine the complaints of patients with Covid-19 more systematically. Conclusion: Spontaneous spinal epidural hematomas are rare. Making the correct diagnosis often takes time and is difficult. Decompression surgery is at the forefront as a treatment option. However, conservative treatment can be performed in suitable patients. As we saw in this case, we should consider Covid-19 among the etiological causes. Highlights:

9 December 2024 in Medicina
Verified
Journal Article
Open access
PDF file
GKGüven Kilic
Güven Kilic
BEBerk Enes Engin
Berk Enes Engin
AHAmir Halabi
Amir Halabi
CTCengiz Tuncer
Cengiz Tuncer
MSMehmet Ali SUNGUR
Mehmet Ali SUNGUR
AGAli Gök
Ali Gök
Objective: Subarachnoid hemorrhage (SAH) is a life-threatening cerebrovascular condition that triggers a robust inflammatory response and cerebral vasospasm. This study aimed to evaluate the effects of anakinra, an interleukin-1 receptor antagonist, and tocilizumab, an interleukin-6 receptor antagonist, on inflammation and vasospasm in an experimental rat SAH model. Methods: Forty male Sprague Dawley rats (200–250 g) were randomly assigned to five groups: control, SAH, SAH + anakinra (ANA), SAH + tocilizumab (TCZ), and SAH + anakinra + tocilizumab (ANA+TCZ). SAH was induced by injecting non-heparinized arterial blood into the cisterna magna. Treatment groups received anakinra (50 mg/kg twice daily), tocilizumab (8 mg/kg once daily), or their combination for three days. Blood and cerebrospinal fluid (CSF) samples were analyzed for inflammatory markers (IL-1, IL-6, TNF-α, CRP), and histopathological evaluations were conducted to assess vasospasm and apoptosis. Results: SAH significantly increased pro-inflammatory cytokines (IL-1, IL-6, TNF-α, CRP) and fibrinogen levels in serum and CSF while reducing the basilar artery lumen diameter (p < 0.001). Anakinra and tocilizumab treatments significantly reduced inflammatory markers and vasospasm severity compared to the SAH group (p < 0.05). Combination therapy was more effective in reducing inflammation and vasospasm than either treatment alone (p < 0.05). Anakinra showed a stronger effect on IL-1 reduction, while tocilizumab was more effective in lowering IL-6 levels. The ANA+TCZ group exhibited a significant decrease in caspase activity, indicating reduced apoptosis (p < 0.05). Conclusions: Anakinra and tocilizumab effectively mitigated inflammation and vasospasm in an experimental SAH model, with combination therapy showing superior efficacy. These findings suggest that targeting both IL-1 and IL-6 pathways may be a promising therapeutic strategy for managing SAH complications. Further studies are warranted to evaluate long-term outcomes and clinical implications.

14 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GKGüven Kilic
Güven Kilic
BEBerk Enes Engin
Berk Enes Engin
AHAmir Halabi
Amir Halabi
CTCengiz Tuncer
Cengiz Tuncer
MSMehmet Ali SUNGUR
Mehmet Ali SUNGUR
ÖPÖmer Polat
Ömer Polat
Background: Subarachnoid hemorrhage (SAH) is a severe neurological condition with high mortality and morbidity rates, often exacerbated by secondary complications such as inflammation, cerebral vasospasm, and apoptosis. Proinflammatory cytokines, including interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), play critical roles in these pathological processes. Anakinra, an IL-1 receptor antagonist, has demonstrated significant anti-inflammatory effects in various disease models. This study aimed to evaluate the efficacy of anakinra in mitigating inflammation, vasospasm, and apoptosis in an experimental rat model of SAH. Methods: Thirty-two male Sprague Dawley rats were divided into four groups: Control (healthy), SAH (no treatment), Saline (0.2 mL saline subcutaneously), and Anakinra (50 mg/kg subcutaneously, twice daily). Proinflammatory markers (CRP, TNF-α, IL-1, IL-6, and fibrinogen) were measured in serum and cerebrospinal fluid (CSF) at 3, 7, and 10 days post-SAH. Basilar artery diameter was evaluated histopathologically, and Caspase-3 expression was assessed immunohistochemically to determine apoptotic activity. Results: SAH significantly increased levels of CRP, TNF-α, IL-1, IL-6, and fibrinogen in both serum and CSF, reduced basilar artery diameter, and elevated Caspase-3 expression compared to the Control group. Saline treatment provided limited improvements, with inflammatory markers and histopathological parameters remaining elevated. Anakinra treatment significantly reduced inflammatory markers, restored basilar artery diameter, and lowered Caspase-3 expression, highlighting its efficacy in mitigating inflammation, vasospasm, and apoptosis. Conclusions: Anakinra effectively suppresses inflammation, alleviates cerebral vasospasm, and inhibits apoptosis in an experimental model of SAH. These findings suggest its potential as a therapeutic agent for managing SAH and its complications. Further research is needed to explore its clinical applicability and long-term effects.

25 February 2026 in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
Verified
Journal Article
Closed access
MYMehmet Emre Yıldırım
Mehmet Emre Yıldırım
ATAyhan Tekiner
Ayhan Tekiner
YEYavuz Erdem
Yavuz Erdem
HÇHaydar Çelik
Haydar Çelik
HKHalil Kul
Halil Kul
ZÇZeliha Çulcu
Zeliha Çulcu
Objective: Methylprednisolone remains one of the most extensively studied pharmacological agents in the treatment of acute spinal cord injury; however, concerns regarding its adverse effects have prompted the investigation of alternative therapeutic strategies. This study aimed to evaluate the neurobehavioral and electrophysiological effects of Modafinil administered alone and in combination with Methylprednisolone in an experimental rat model of spinal cord injury.Methods: Twenty-five male Wistar Albino rats were randomly divided into five groups. Following laminectomy and standardized spinal cord trauma, Modafinil and/or Methylprednisolone were administered according to group allocation. Neurobehavioral recovery was assessed using the Inclined Plane Test, and electrophysiological evaluation was performed using motor evoked potential recordings.Results: A statistically significant difference in inclined plane angles was observed between the groups on postoperative day 1 (p < 0.01). Groups 4 and 5 demonstrated significantly higher functional scores compared to Group 2, whereas no significant difference was observed between Groups 2 and 3. In within-group analysis, functional improvement between day 1 and day 10 was significant in Groups 4 and 5 but not in Groups 1 and 2. Early post-traumatic amplitudes decreased significantly in all trauma groups. Late amplitude measurements demonstrated significant recovery within treatment groups, with greater improvement observed in the combined treatment group.Conclusion: Modafinil demonstrated beneficial neurobehavioral and electrophysiological effects in this experimental spinal cord injury model. The combined administration of Modafinil and Methylprednisolone resulted in greater functional and electrophysiological recovery, suggesting a potential synergistic effect. Further experimental and clinical studies are required to clarify its therapeutic role.

31 May 2022 in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
Verified
Journal Article
Closed access
YEYavuz Erdem
Yavuz Erdem
SDSamet Di̇nç
Samet Di̇nç
AKAdem Kurtuluş
Adem Kurtuluş
Objective: SARS-CoV-2 is a pandemic that still causes high mortality and morbidity in our world. We observed and wanted to examine the high mortality and morbidity rates of SARS-CoV-2 due to lung and other organ involvement, and even more mortality in the presence of accompanying intracranial events.Methods: This study is a single-center retrospective cohort study. Patients who applied to Afyonkarahisar State Hospital between June 2020 and June 2021, who were evaluated as SARS-CoV-2 in their current state and who were found to have an intracranial hemorrhage, were evaluated.Results: Of the 13 patients in our cohort, 7 (54%) had comorbidities such as hypertension, diabetes mellitus, and chronic renal failure. The intraparenchymal hematoma was observed in 5 patients, chronic subdural hematoma in 2 patients, acute subdural hematoma in 1 patient, and subarachnoid hemorrhage in 4 patients. Decompressive craniectomy and hematoma evacuation were performed on 5 patients in our study. Nine of the patients included in our study died as a result of their follow-up and treatment in the intensive care unit, and the mortality rate was 69%.Conclusion: Intracranial hemorrhages may occur rarely in patients with SARS-CoV-2 infection, and it is observed that intracerebral hemorrhages, which are already quite mortal, are more mortal. In addition, COVID-19 infection is thought to be a risk factor for intracranial hemorrhages.

1 September 2022 in Black Sea Journal of Health Science
Verified
Journal Article
Closed access
PDF file
GKGözde Kurtuluş
Gözde Kurtuluş
STSerdar Tokmak
Serdar Tokmak
SDSamet Di̇nç
Samet Di̇nç
AKAdem Kurtuluş
Adem Kurtuluş
Clear cell hydroadenocarcinoma is a very rare sweat gland tumor. It has an aggressive course and has a high recurrence rate. Wide excision is the first option in the treatment of this tumor with a high rate of metastasis. Subsequent radiotherapy and chemotherapy are still controversial. In this case, we presented a patient who was operated on and presented with a lipoma-like appearance on the scalp. The pathology result of the patient was Clear cell hidradenocarcinoma. We emphasized that in operations performed with the preliminary diagnosis of lipoma on the scalp, this diagnosis should be included among the preliminary diagnoses and resection should be performed as widely as possible.